[ 1 ] Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum cal-cium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study[J]. Kidney Int, 2006, 70(2): 351-357.
[ 3 ] Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis[J]. JAMA, 2011, 305(11): 1119-1127.
[ 5 ] Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to henodialysis[J]. Kidney Int, 2005, 68(4): 1815-1824.
[6]
[ 6 ] Sprague SM, Abboud H, Qin P, et al. Lanthanum carbonate reduces phosphorus burder in patients with CKD stage 3 and 4: a randomized trial[J]. Clin J Am Soc Nephrol, 2009, 4(1): 178-185.
[ 8 ] Davenport A, Gardner C, Delaney M, et al. The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit[J]. Nephrol Dial Transplant, 2010, 25(3): 897-901.
